Saltar al contenido

Kenianische Mediziner schlagen Alarm wegen der Zunahme von Lungenentzündungs- und Tuberkulosefällen

#Kenianische #Mediziner #schlagen #Alarm #wegen #der #Zunahme #von #Lungenentzündungs #und #Tuberkulosefällen Gesundheit Kenianische Mediziner schlagen Alarm wegen der Zunahme von Lungenentzündungs- und Tuberkulosefällen Mittwoch, 20. März 2024 Der Anstieg von Atemwegserkrankungen ist vor allem bei Kindern und jungen Erwachsenen zu beobachten. FOTO | SHUTTERSTOCK Ärzte haben wegen der zunehmenden Fälle von Lungenentzündung und Tuberkulose, insbesondere […] Kenianische Mediziner schlagen Alarm wegen der Zunahme von Lungenentzündungs- und Tuberkulosefällen

TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

FORT WORTH, March 20, 2024 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that it has entered into definitive agreements for the purchase and sale of 147,500 shares of common stock at a purchase price of $8.00 per share in a registered direct offering priced at-the-market under Nasdaq rules. In a concurrent private placement, the Company will issue unregistered warrants to purchase up to 147,500 shares of common stock at an exercise price of $8.00 per share that will be immediately exercisable upon issuance and will expire five and one-half years following the date of issuance. The closing of the offering is expected to occur on or about March 22, 2024,… 

Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device

SALT LAKE CITY, March 20, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that the U.S. Patent and Trademark Office has granted a patent that covers the use of push-button blood collection devices for PCR-based fetal sex determination. Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device

MediciNova Announces Two Abstracts regarding MN-001 (tipelukast) and MN-002 Accepted for Presentation at the 92nd EAS 2024 Congress, the Annual Meeting of the European Atherosclerosis Society

LA JOLLA, Calif., March 20, 2024 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that two abstracts entitled “STUDY PROTOCOL TO EVALUATE MN-001’S (TIPELUKAST) EFFICACY, SAFETY AND TOLERABILITY IN SUBJECTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), HYPERTRIGLYCERIDEMIA (HTG) AND TYPE-2 DIABETES MELLITUS (T2DM)” and “MN-002, THE METABOLITE OF MN-001(TIPELUKAST) PROMOTES MACROPHAGE CHOLESTEROL EFFLUX” have been accepted and selected for poster presentation at the 92nd European Atherosclerosis Society (EAS) 2024 Congress to be held May 26-29, 2024. MediciNova Announces Two Abstracts regarding MN-001 (tipelukast) and MN-002 Accepted for Presentation at the 92nd EAS 2024 Congress, the Annual Meeting of the European Atherosclerosis Society

Roche eröffnet Entwicklungszentrum für Gentherapie in Penzberg

In der neuen Hightech-Einrichtung treibt Roche künftig die Entwicklung von Genvektoren für neuartige Gentherapien voran. Zudem sollen diese hier im Industriemaßstab für klinische Studien hergestellt werden. Diese Genvektoren, oder auch „Genfähren“ genannt, eröffnen als Transportvehikel für DNA völlig neuartige Möglichkeiten, die Ursachen verschiedenster schwerer Erkrankungen auf DNA-Ebene zu behandeln und künftig sogar heilen zu können. Laut der American Society of Gene & Cell Therapy (ASGCT) wurden Ende 2023 weltweit mehr als 2.000 Gentherapien und genetisch modifizierte Zelltherapien erforscht. In der EU und somit in Deutschland sind aktuell 15 Gentherapien zugelassen (Quelle: Verband der forschenden Arzneimittelhersteller, VfA, Februar 2024).

Clinical proteomics: 100x more robust and 10x faster

A revolutionary approach simplifies and enhances the proteomic analysis of minimal cell quantities and liquid biopsies, setting a new standard in sensitivity, throughput, and robustness. By streamlining sample preparation for mass spectrometry, the Evotip workflow enables the seamless, cost-effective identification of proteins from biological matrices like blood plasma. This advancement paves the way for unprecedented insights into diseases at a molecular level, facilitating the discovery of precise biomarkers and therapeutic targets. Evotip based workflows not only accelerate scientific discovery but also makes state-of-the-art proteomics more accessible, promising significant strides in personalized medicine and beyond https://www.nature.com/articles/s41467-024-46777-9.epdf

NVIDIA Generative AI:  Drug Discovery and Design

NVIDIA BioNeMo, which is fueling the computer-aided drug discovery ecosystem, now features more than a dozen generative AI models and cloud services. In perhaps the healthcare industry’s most dramatic transformation since the advent of computing, digital biology and generative AI are helping to reinvent drug discovery, surgery, medical imaging and wearable devices. NVIDIA Generative AI Is Opening the Next Era of Drug Discovery and DesignNVIDIA BioNeMo, which is fueling the computer-aided drug discovery ecosystem, now features more than a dozen generative AI models and cloud services.January 8, 2024 by Kimberly Powell Share  In perhaps the healthcare industry’s most dramatic transformation since the advent of computing, digital biology and generative AI are helping to reinvent drug discovery, surgery, medical imaging and wearable devices. NVIDIA has been preparing for this moment for over a decade, building deep domain expertise, creating the NVIDIA… 

Ransomware-Angriff eines Anbieters legt Patientendaten in einem Krankenhaus in Tennessee offen

Die Informationen von Regional One Health mit Sitz in Memphis, Tennessee, in den Bereichen Geburtshilfe und Gynäkologie könnten durch einen Ransomware-Angriff auf den Technologieanbieter KMJ Health Solutions kompromittiert worden sein. Am 18. Januar teilte KMJ dem University of Tennessee Health Science Center, das Bewohner von Regional One versorgt, mit, dass sein Hosting-Anbieter Liquid Web Anzeichen […] Ransomware-Angriff eines Anbieters legt Patientendaten in einem Krankenhaus in Tennessee offen

CRISPR-based diagnostics detecting oral pathogens

The study, by Batbileg Bor of the ADA Forsyth Institute, Cambridge, MA, USA, tailored the novel CRISPR-Cas-based diagnostic platform Specific High-Sensitivity Enzymatic Reporter Unlocking (SHERLOCK) for the species-specific detection of oral bacterial pathogens and human papillomavirus (HPV) nucleic acids. The investigators developed a computational pipeline capable of generating guide-RNAs and species-specific gene primers suitable for SHERLOCK. These constructs were synthesized by cell-free biosynthesis systems, and their specificity and sensitivity were experimentally validated by fluorescence readings of reporter RNAs. The study achieved the detection of oral bacteria within the single-molecule range that remained specific in the presence of off-target DNA found within saliva. Furthermore, the assay was refined for detecting common oral pathogens (e.g., P. gingivalis, F. nucleatum) directly from unprocessed saliva samples. The results of the detection, when tested on 30 patient saliva samples, fully aligned with those of other…